Results 191 to 200 of about 5,802,672 (263)

Draft genome sequence of the mammalian pathogenic <i>Paralagenidium karlingii</i>. [PDF]

Microbiol Resour Announc
Goncalves Ramos M, Yu F, Barber R, Nance-Richey R, Gilbertie J, Kaplan-Hsu A, Goss EM, Santoro D, Rodrigues Hoffmann A.   +8 more
europepmc   +1 more source

Integrated PANoptosis Profiling Identifies Immunosuppressive Subtypes and a Prognostic Signature With Functional Validation of MLKL in Glioblastoma

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The prognosis of glioblastoma (GBM) remains highly unfavorable, largely due to high tumor heterogeneity and an immunosuppressive microenvironment. However, the functional role of PANoptosis in this context is poorly understood. Methods Patients were stratified via K‐means clustering. A risk score model was constructed using prognosis‐
Langfei Tian, Minghui Zhao, Yuanbo Hu, Kaiyue Wang, Haiguang Liu, Zetong Bai, Kebin Zheng   +6 more
wiley   +1 more source

The correlation between surgical, anaesthetic and obstetric workforce and surgical volume: a modelling study. [PDF]

Front Health Serv
Ng YJ, van Duinen AJ, Bolkan HA, Gadgil A, Patil P, Roy N.   +5 more
europepmc   +1 more source

Validation of a Cellular Imaging‐Based Method as a Potential Biomarker for SPG4 Hereditary Spastic Paraplegia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Hereditary Spastic Paraplegia (HSP) comprises a group of rare genetic diseases characterized by length‐dependent axonal degeneration of the corticospinal tracts and dorsal columns, whose main clinical feature is spastic gait. Pathogenic variants in the SPG4 gene cause Spastic Paraplegia Type 4 (SPG4‐HSP), the most common form of HSP.
Gaia Fattorini, Valerio Licursi, Gianmarco Dalla Zanna, Flavio Dal Canto, Melissa Barghigiani, Nunzio Setola, Salvatore Rossi, Antonio Funcis, Filippo M. Santorelli, Gabriella Silvestri, Carlo Casali, Francesca Sardina, Cinzia Rinaldo   +12 more
wiley   +1 more source

Prioritizing context-specific genetic risk mechanisms in 11 solid cancers. [PDF]

J Natl Cancer Inst
Wu X, Kim A, Breeze CE, O'Mara TA, Ramachandran D, Dörk T, Koutros S, Rothman N, Prokunina-Olsson L, Mancuso N, Lindström S, Kraft P.   +11 more
europepmc   +1 more source

Comparison of outcomes after SMILE using VISUMAX 800 and VISUMAX 500 for correcting myopia and myopic astigmatism: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Li G, Li Y.
europepmc   +1 more source